AR240832A2 - Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico. - Google Patents

Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico.

Info

Publication number
AR240832A2
AR240832A2 AR30120485A AR30120485A AR240832A2 AR 240832 A2 AR240832 A2 AR 240832A2 AR 30120485 A AR30120485 A AR 30120485A AR 30120485 A AR30120485 A AR 30120485A AR 240832 A2 AR240832 A2 AR 240832A2
Authority
AR
Argentina
Prior art keywords
hydroxy
amino
propan
diphosphonate
water
Prior art date
Application number
AR30120485A
Other languages
English (en)
Other versions
AR240832A1 (es
Original Assignee
Ciba Geigy Ag Henkel Kommandit
Ien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4263070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR240832(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag Henkel Kommandit, Ien filed Critical Ciba Geigy Ag Henkel Kommandit
Application granted granted Critical
Publication of AR240832A2 publication Critical patent/AR240832A2/es
Publication of AR240832A1 publication Critical patent/AR240832A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 3-AMINO-1-HIDROXI-PROPAN-1,1-DIFOSFONATO DISODICO DE LA FORMULA (I), EN FORMA NO-HOGROSCOPICA, CRISTALINA, CONTENIENDO AGUA DE CRISTALIZACION, MEDIANTE LA DISOLUCION DE 3-AMINO-1-HIDROXI-PROPAN-1,1-DIFOSFANATO DISODICO EN AGUA A 70 C-80 C O POR NEUTRALIZACION DE ACIDO 3-AMINO-1-HIDROXI-PROPAN-1,1-DIFOSFONICO CON LA SOLUCION ACUOSA DE UNA SAL DE SODIO BASICA A 35 C-85 C, SE ELABORA UNA SOLUCION ACUOSA DE 10%- 55% DE 3-AMINO-1-HIDROXI-PROPAN-1,1-DIFOSFONATO DISODICO, SE CONCENTRA A 70 C-80 C EN TAL MEDIDA QUE EL PUNTO DE SATURACION SE UBICA ENTRE LAS TEMPERATURAS DE 50 C A 70 C, SE ENFRIA EL MISMO, LUEGO DE INICIADA LA FORMACION DE CRISTALES, BAJO EVENTUAL AGREGADO DE 20 A 45% POR VOLUMEN (REFERIDO A LA CANTIDAD TOTAL DE AGUA) DE UN ALCANO INFERIOR MISCIBLE CON AGUA A 25 C-0 C, SE ACUMULAN LOS CRISTALES FORMADOS Y LOS MISMOS SE SECAN A 15 C-60 C, HASTA ALCANZAR CONSTANCIA EN EL PESO.
AR301204A 1984-08-06 1985-08-06 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico. AR240832A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH376884 1984-08-06

Publications (2)

Publication Number Publication Date
AR240832A2 true AR240832A2 (es) 1991-02-28
AR240832A1 AR240832A1 (es) 1991-02-28

Family

ID=4263070

Family Applications (4)

Application Number Title Priority Date Filing Date
AR301204A AR240832A1 (es) 1984-08-06 1985-08-06 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico.
AR89314300A AR244697A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico
AR89314299A AR244696A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico.
AR89314298A AR244698A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico.

Family Applications After (3)

Application Number Title Priority Date Filing Date
AR89314300A AR244697A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico
AR89314299A AR244696A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico.
AR89314298A AR244698A1 (es) 1984-08-06 1989-06-29 Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-1,1-difosfonato disodico.

Country Status (26)

Country Link
US (2) US4639338A (es)
EP (1) EP0177443B1 (es)
JP (1) JPS6143196A (es)
KR (1) KR940000817B1 (es)
AR (4) AR240832A1 (es)
AT (1) ATE47396T1 (es)
AU (1) AU591066B2 (es)
CA (1) CA1255694A (es)
CY (1) CY1570A (es)
DD (1) DD239597A5 (es)
DE (1) DE3573783D1 (es)
DK (1) DK167282B1 (es)
DO (1) DOP1990004769A (es)
ES (2) ES8701188A1 (es)
FI (1) FI79712C (es)
GR (1) GR851910B (es)
HK (1) HK42591A (es)
HU (1) HU193124B (es)
IE (1) IE58077B1 (es)
IL (1) IL75990A (es)
MX (1) MX9203373A (es)
NO (1) NO165401C (es)
PH (1) PH24854A (es)
PT (1) PT80916B (es)
SG (1) SG91390G (es)
ZA (1) ZA855892B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
TW237386B (es) 1992-04-15 1995-01-01 Ciba Geigy
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
JP3266395B2 (ja) * 1993-11-24 2002-03-18 富士写真フイルム株式会社 有機薬品の晶析方法
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PT891979E (pt) * 1997-07-15 2005-02-28 Gador Sa Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao
PT1107974E (pt) * 1998-08-27 2006-10-31 Teva Pharma Novas formas de hidratos de alendronato de sodio, processos para a sua producao e suas composicoes farmaceuticas
EP1702924A3 (en) * 1998-08-27 2007-07-18 Teva Pharmaceutical Industries Ltd Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
CA2353942A1 (en) * 1998-12-10 2000-06-15 Edward C. Shinal Method for preparation of disodium pamidronate
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
KR100343232B1 (ko) * 1999-12-10 2002-07-10 김재윤 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법
CA2406446A1 (en) * 2000-09-18 2002-03-21 Gregory Paul Handreck Diphosphonate solutions
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
CA2445584A1 (en) 2001-05-02 2002-11-07 Sicor Inc. Injectable pamidronate disodium
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
NZ552514A (en) * 2001-12-24 2008-08-29 Teva Pharma Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
SI1596870T2 (sl) * 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
AU2003286309A1 (en) * 2003-12-04 2005-06-24 Mustafa Nevzat Ilac Sanayii A.S. Method for producing pure disodium pamidronate
PT2269584T (pt) 2004-05-24 2022-07-01 Theramex Hq Uk Ltd Forma de dosagem oral entérica sólida de um bisfosfonato contendo um agente quelante
EP1802641B8 (en) * 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
JP2009530414A (ja) * 2006-03-17 2009-08-27 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ ビスホスホネート化合物及び方法
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
DK2473172T3 (en) 2009-09-01 2015-06-15 Univ Duke BISPHOSPHONATSAMMENSÆTNINGER and Methods for treating congestive heart failure
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
US20130138221A1 (en) 2010-04-16 2013-05-30 Novartis Ag Methods and compositions for improving implant osseointegration
CA2856030A1 (en) 2011-11-16 2013-05-23 Duke University Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
NZ702414A (en) * 2012-05-14 2016-10-28 Antecip Bioventures Ii Llc Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
KR101995432B1 (ko) * 2016-10-13 2019-07-02 엘지전자 주식회사 공기조화기 및 그 제어방법
EP3553067A1 (en) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph of sodium neridronate and preparation process thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
JPS5283957A (en) * 1975-12-01 1977-07-13 Henkel & Cie Gmbh Medicine for treating metabolic obstruction of calcium
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DK506476A (da) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Farmaceutiske preparater til behandling af calciumstofs skifteforstyrrelser
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
DE2702631A1 (de) * 1977-01-22 1978-07-27 Henkel Kgaa Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren
DE2943498C2 (de) * 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) * 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
US4639338A (en) 1987-01-27
HUT38361A (en) 1986-05-28
IL75990A (en) 1989-07-31
ES545899A0 (es) 1986-11-16
DOP1990004769A (es) 1999-08-19
FI79712B (fi) 1989-10-31
CA1255694A (en) 1989-06-13
DK167282B1 (da) 1993-10-04
HU193124B (en) 1987-08-28
AR244696A1 (es) 1993-11-30
AR244698A1 (es) 1993-11-30
NO853087L (no) 1986-02-07
DK355485D0 (da) 1985-08-05
GR851910B (es) 1985-12-03
AU591066B2 (en) 1989-11-30
KR860001821A (ko) 1986-03-22
ATE47396T1 (de) 1989-11-15
AU4577785A (en) 1986-02-13
EP0177443A1 (de) 1986-04-09
ZA855892B (en) 1986-03-26
FI79712C (fi) 1990-02-12
IE58077B1 (en) 1993-06-30
DE3573783D1 (en) 1989-11-23
ES555602A0 (es) 1987-07-01
DK355485A (da) 1986-02-07
MX9203373A (es) 1992-09-01
FI852986L (fi) 1986-02-07
NO165401C (no) 1991-02-06
AR240832A1 (es) 1991-02-28
PT80916B (pt) 1987-12-30
HK42591A (en) 1991-06-07
SG91390G (en) 1991-01-18
IE851931L (en) 1986-02-06
FI852986A0 (fi) 1985-08-02
PT80916A (en) 1985-09-01
AR244697A1 (es) 1993-11-30
NO165401B (no) 1990-10-29
ES8706707A1 (es) 1987-07-01
DD239597A5 (de) 1986-10-01
KR940000817B1 (ko) 1994-02-02
US4711880A (en) 1987-12-08
JPH058717B2 (es) 1993-02-02
JPS6143196A (ja) 1986-03-01
PH24854A (en) 1990-12-26
EP0177443B1 (de) 1989-10-18
CY1570A (en) 1991-12-20
ES8701188A1 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
AR240832A2 (es) Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico.
ES8105378A1 (es) Proteccion de obtencion de concentrados de limpieza a base de acidos poliacrilicos modificados.
SE439416B (sv) Anvendning av fosfinsyror respektive fosfinsyrasalter for att bekempa icke onskverd vegetation
BR8401199A (pt) Compostos peroxigenados em forma de sais solidos,processo para a fabricacao de sal monopotassico ou monomagnesio de acido 4-sulfoperbenzoico,composicoes que os contem,e processo ou composicao para lavagem e/ou alvejamento e/ou saneamento e/ou desinfeccao
ES2101004T3 (es) Formulacion estable de sales del enalapril, procedimiento para su preparacion y su uso.
ES470458A1 (es) Procedimiento para la obtencion de sales de 1-(2-feniletil) triazolio de efecto fungicida
ES2188715T3 (es) Sales edulcorantes.
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
AR202685A1 (es) Procedimiento para mantener en valores muy bajos la proporcion de cianuro en los banos de sal que contienen cianatos
MX155976A (es) Procedimiento para la preparacion de la medificacion cristalina d de la sal de sodio del derivado oximido del acido 7-amino tiazolil acetamidocefalosporanico
AR240924A2 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
ES2002112A6 (es) Un metodo para preparar sales cristalinas de cefalosporinas semisinteticas, particularmente de 7-(alfa-(2-aminotiazol-4-il)-alfa-(z)-metoximinoacetamido)-3-((1-metil-1-pirrolidinio)-metil)-3-cefem-4-carboxilato
ES8405830A1 (es) Procedimiento para preparar colorantes diazoicos.
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
ES2097926T5 (es) Uso de derivados de los acidos 1,3,5-triazin-2,4,6-tris-alquilaminocarboxilicos como agentes biocidas.
DK390384D0 (da) Midler med antimikrobiel virkning indeholdende derivater af benzoesyr og deres anvendelse som desinficerende laegemidler eller konserveingsmidler
ES2029836T3 (es) Procedimiento para preparar un derivado de pristinamicina.
ATE114714T1 (de) Verfahren zur kristallisation von subtilisin.
ES8308551A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES2029023T3 (es) Un composicion detergente para lavado de tejidos.
IT1119047B (it) Dispositivo tenditore di trama per telai senza navetta
ES8302647A1 (es) Un procedimiento para la preparacion de guanidinas
SE7609229L (sv) Medel for selektiv ogresbekempning i betor
BR8101196A (pt) Composicao aquosa para escurecimento de material queratinoso
DK401683A (da) Substituerede benzensulfonsyreestere, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler